TAIGA BIOTECHNOLOGIES
Taiga Biotechnologies is a clinical-stage company focused on harnessing the immune system to fight infectious disease and cancer. The company's Bone Marrow Engraftment Enhancer (BMEE) program is developing a first-line product, TBX-1400, to enhance the engraftment of hematopoietic stem and progenitor cells during an allogeneic hematopoietic stem cell transplant (HSCT). Taiga Biotechnologies lead Cell-Based Immunotherapy product candidate, TBX-3400, uses a patient’s own immune cells to help fi... ght against cancer and infectious disease. TBX-3400 is an autologous cell product made from peripheral blood mononuclear cells that are treated ex vivo with our fusion protein and then delivered intravenously back to the patient the following day. They developing technologies to generate red blood cells in the laboratory for clinical applications and products to improve the utility of red blood cell products.
TAIGA BIOTECHNOLOGIES
Social Links:
Industry:
Biotechnology Life Science Therapeutics
Founded:
2006-01-01
Address:
Aurora, Colorado, United States
Country:
United States
Website Url:
http://www.taigabiotech.com
Total Employee:
11+
Status:
Active
Contact:
(720) 859-3547
Email Addresses:
[email protected]
Total Funding:
52.26 M USD
Technology used in webpage:
Domain Not Resolving SPF Microsoft Exchange Online Google Office 365 Mail Google Cloud Wix Google Cloud Global Multi-Region Wix DNS Wix Hosted
Similar Organizations
Akero Therapeutics
Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.
Exacis Biotherapeutics
Exacis is a development-stage immuno-oncology company focused on harnessing the human immune system to cure cancer.
Jounce Therapeutics
Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Symphony Biosciences
Symphony Biosciences empowers the immune system to fight cancer.
Founder
Official Site Inspections
http://www.taigabiotech.com Semrush global rank: 13.22 M Semrush visits lastest month: 78
Unable to get host informations!!!
More informations about "Taiga Biotechnologies"
Taiga Biotechnologies, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Taiga Biotechnologies, Inc. of Aurora, CO. Get the latest business insights from Dun & Bradstreet.See details»
Taiga Biotechnologies - ZoomInfo
Feb 8, 2021 View Taiga Biotechnologies (www.taigabiotech.com) location in Colorado, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Taiga Biotechnologies - Craft
Taiga Biotechnologies is a biotech company specializing in therapeutic approaches to treat hematological diseases, including cancers, immunodeficiencies, and autoimmune conditions. …See details»
Taiga Biotechnologies - LinkedIn
Taiga Biotechnologies Biotechnology Research Aurora, CO 781 followers Taiga Biotechnologies is a clinical stage biotechnology company focused on harnessing the power of the immune …See details»
Taiga Biotechnologies - Products, Competitors, Financials, …
Taiga Biotechnologies is a clinical stage biotechnology company in the health sector. The company develops cell-based therapies that utilize a patient's own immune cells and stem …See details»
Taiga Biotechnologies - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Taiga Biotechnologies. Use the PitchBook Platform to explore the full profile.See details»
Taiga Biotechnologies Company Profile | Management and
Find contact information for Taiga Biotechnologies. Learn about their Business Services market share, competitors, and Taiga Biotechnologies's email format.See details»
TAIGA BIOTECHNOLOGIES, INC. - VentureRadar
Privately Held "Taiga Biotechnologies is developing novel therapies for complex diseases including cancers, infectious agents such as HIV and influenza, and hematologic conditions …See details»
Taiga Biotechnologies Overview | SignalHire Company Profile
Taiga Biotechnologies is a private company that has been in the industry for 18 years. The company currently specializes in the Biotechnology area. The position of the Co-Founder & …See details»
Taiga Biotechnologies Management Team | Org Chart - RocketReach
Taiga Biotechnologies Management Taiga Biotechnologies employs 5 employees. The Taiga Biotechnologies management team includes Jim Kelly (Chief Financial Officer), Robert Gulock …See details»
Taiga Biotechnologies, Inc. - govtribe.com
UEI XL65VT7VCRN8 Taiga Biotechnologies is a clinical stage biotechnology company focused on developing a new class of cell-based therapies utilizing autologous immune cells and …See details»
Taiga Biotechnologies Company Profile - Selligence
Taiga Biotechnologies is a clinical-stage company focused on harnessing the immune system to fight infectious disease and cancer.See details»
Taiga Biotechnologies - Company profile | ensun
Who is Taiga Biotechnologies? Taiga Biotechnologies, Inc. is developing a new class of cell-based therapies utilizing autologous immune cells and allogeneic stem cells. New class of …See details»
Taiga Biotech - Company Profile - Tracxn
Oct 20, 2024 Taiga Biotech - Cellular therapies for hematological diseases.. This company is not active anymore. Raised a total funding of $26.9M over 7 rounds from 1 investor.See details»
TAIGA BIOTECHNOLOGIES, INC. - VentureRadar
Neuronascent, Inc. is a pioneering biotechnology company focused on developing innovative therapies for neurodegenerative diseases. Utilizing cutting-edge research and development, …See details»
Taiga Biotechnologies CEO, Founder, Key Executive Team, Board of ...
Explore {Taiga Biotechnologies's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
TBX-2400 in Myelofibrosis and Acute Myelogenous Leukemia
Jan 12, 2021 This is a study of allogeneic stem cell transplantation with TBX-2400 in adult subjects with Acute Myelogenous Leukemia (AML) or Myelofibrosis (MF).The donor ce...See details»
Taiga Biotechnologies Awarded Orphan Drug Designation for …
Jun 13, 2016 The FDA has given Taiga Biotechnologies Orphan Drug Designation for an experimental product designed to treat children with a rare immune deficiency tSee details»
Taiga Initiates Phase 1/2 Clinical Study of TBX-2400 in Acute …
Nov 10, 2021 For more information, please visit the company's website (www.taigabiotech.com). This press release contains forward-looking statements within the meaning of The Private …See details»